IP Verse

Astrazeneca Pharmaceuticals Lp V. Cipla Limited - 3:24-cv-08167

Astrazeneca Pharmaceuticals Lp V. Cipla Limited (Case No. 3:24-cv-08167), filed on Jul 31, 2024 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
3:24-cv-08167
Filing Date
Jul 31, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
ASTRAZENECA UK LIMITED -
CIPLA USA, INC. -
MSD INTERNATIONAL BUSINESS GMBH -
KUDOS PHARMACEUTICALS LIMITED -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 07/31/2024)PACER Document
Jul 31, 2024Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (kht)PACER Document
Jul 31, 2024AO120 Patent/Trademark Form filed. (kht) (Entered: 07/31/2024)PACER Document
Jul 31, 2024SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 07/31/2024)PACER Document
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment
Jul 31, 2024COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15556746), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A ('695 patent), # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 07/31/2024)Attachment